Scopus BioPharma has Huge Scope for Growth. Find Out How!
Scopus BioPharma, Inc. (NASDAQ: SCPS), a biopharmaceutical company, announced the approval of an investigational drug application (IND) for CpG-STAT3siRNA, an immuno-oncology RNA therapy...
Coverage
- All
- Beauty
- Biotechnology
- Cannabis
- Communications
- Education
- Energy
- Entertainment
- Environment
- ETFs
- Finance
- Fitness
- Food and Beverage
- Healthcare
- Hospitality
- Insider Trading
- Investing Ideas
- Macro
- Market Insight
- Miscellaneous
- Power
- Real Estate
- Retail
- Sectors
- Security
- Startups
- Technologies
- Trending
- Uncategorized
5 Stocks that are all set to create waves in the coming days!
While Industries across the globe are grappling with the pandemic and its impact on their operations, Technology Industry has been focused on minimizing...
4 Reasons Why You Should Put Surface Oncology on your Watchlist!
A clinical stage Immuno-oncology company, Surface Oncology, Inc. (NASDAQ: SURF) is developing a diverse pipeline of candidates that target the immune system...
SciPlay Corporation is stepping up its Game! Is it Enough?
A premier developer and publisher of digital games, SciPlay Corporation (NASDAQ: SCPL) offers free-to-play casino, casual and bingo games to millions of users...
Onconova Upbeat about the prospects of its CDK 4/6 Inhibitors!
A Clinical-stage biopharmaceutical company, Onconova Therapeutics, Inc. (NASDAQ: ONTX) is developing novel therapeutics to combat cancer. The Company is developing a pipeline of...
Fluent Inc – Will its Traffic Quality Initiative Pay Off?
Fluent, Inc. (NASDAQ: FLNT) is a data driven marketing services provider that offers performance and data solutions. The Company was founded in 2010...
5 Biotech Stocks with Upcoming Catalysts!
Biotech Companies continue to show resurgence even in these challenging times, with more and more companies persevering with bringing their clinical candidates to...
Can Minerva Neurosciences Roluperidone be a Turning Point in Schizophrenia Treatment?
A clinical-stage company Minerva Neurosciences, Inc. (NASDAQ: NERV) is developing an array of products for treating Central Nervous System (CNS) disorders, this biopharmaceutical...
Will Second Sight Medical Products Hit the Bull’s-Eye with Orion®?
Second Sight Medical Products, Inc. (NASDAQ: EYES), a developer of leading-edge implantable visual prosthetics, announced the results from a two-year study evaluating the...
